Showing 5471-5480 of 5621 results for "".
- Alcon Adds New Ultraviolet-Absorbing Only IOL Options to its AcrySof Portfoliohttps://modernod.com/news/alcon-adds-new-ultraviolet-absorbing-only-iol-options-to-its-acrysof-portfolio/2479895/Alcon expanded its AcrySof IOL portfolio with the introduction of multifocal and multifocal toric ultraviolet (UV)-absorbing IOLs, as well as the introduction of the AcrySof UV-Absorbing monofocal IOL with the UltraSert Preloaded Delivery System. “At Alcon, input from our surgeons is at th
- Oculus Announces Release of Smartfield Smart Compact Perimeterhttps://modernod.com/news/oculus-announces-release-of-smartfield-smart-compact-perimeter/2479897/Oculus has announced the release of its Smartfield perimeter, expanding its portfolio of compact visual field testing devices. The new Smartfield has been optimized specifically for examinations for functional impairment of the central visual field, but is also suited for peripheral measurements.
- Apellis Announces First Patient Dosed in Its Phase 3 Clinical Program for APL-2 in Patients With Geographic Atrophyhttps://modernod.com/news/apellis-announces-first-patient-dosed-in-its-phase-3-clinical-program-for-apl-2-in-patients-with-geographic-atrophy/2479898/Apellis Pharmaceuticals announced that it has commenced its phase 3 clinical program for APL-2 in patients with geographic atrophy (GA), consisting of two phase 3 trials (DERBY & OAKS.) The first patient has been dosed in the OAKS trial and the first patient has been enrolled in the
- SightMD, 24-Location Ophthalmology Group, and Chicago Pacific Founders Set Partnershiphttps://modernod.com/news/sightmd-24-location-ophthalmology-group-and-chicago-pacific-founders-set-partnership/2479899/SightMD, a provider of eyecare services through 24 locations, and Chicago Pacific Founders Fund LP, a health care investment fund, announced that they are entering into a partnership to expand SightMD’s patient-centric care model to patients, providers, and payers across the New York, New Jersey
- New Joystick for the Keratograph 5M With Release Functionhttps://modernod.com/news/new-joystick-for-the-keratograph-5m-with-release-function/2479900/The Oculus Keratograph 5M now comes equipped with a new joystick, which includes a release function. The new feature enables the user to capture images and video sequences with the push of a button on the device. No need any more to switch to the mouse – the user’s hand stays resting on the new
- Gaming for an Independent Life: Hope for Visually Impaired Children with New Computer Gamehttps://modernod.com/news/gaming-for-an-independent-life-hope-for-visually-impaired-children-with-new-computer-game/2479909/A new computer game, which developers say could help visually-impaired children lead independent lives, has been rolled out online and it is being made freely available for families, schools, and healthcare providers. The browser-based game, called Ey
- Contact Lens Companies Seek Summary Judgment in Lawsuit Over Minimum Pricinghttps://modernod.com/news/contact-lens-companies-seek-summary-judgment-in-lawsuit-over-minimum-pricing/2479910/Three contact lens companies and a distributor, who are defendants in a class-action lawsuit over pricing, filed a motion seeking a summary judgment in the matter in U.S. District Court for the Middle District of Florida here earlier this week, according to a
- Adolescents With Strabismus More Likely to Have Psychological Problemshttps://modernod.com/news/adolescents-with-strabismus-more-likely-to-have-psychological-problems/2479912/Adolescents with visible eye deviation due to strabismus may be prone to psychological problems, researchers in Turkey report. “The visible eye deviation caused by strabismus was a strong indicator of psychological distress in
- FDA Approves First Drug for Neurotrophic Keratitishttps://modernod.com/news/fda-approves-first-drug-for-neurotrophic-keratitis/2479917/The FDA approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea. “While the prevalence of neurotrophic keratitis is low, the impact of this serious condition on an individual patient can be devastating,” Wiley Chamber
- Staying Fit Might Cut Glaucoma Riskhttps://modernod.com/news/staying-fit-might-cut-glaucoma-risk/2479921/Meeting physical activity guidelines and being physically fit may reduce the risk of developing glaucoma by 40 percent to 50 percent, recent research suggests, according to a Reuters